High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group
Authors:
Open Access
- 4 July 2013
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 162 (5) , 670-677
Abstract
Summary: Ectopic viral integration site‐1 (EVI1) is highly expressed in certain cytogenetic subsets of adult acute myeloid leukaemia (AML), and has been associated with inferior survival. We sought to examine the clinical and biological associations of EVI1high, defined as expression in excess of normal controls, in paediatric AML. EVI1 mRNA expression was measured via quantitative real‐time polymerase chain reaction in diagnostic specimens obtained from 206 patients. Expression levels were correlated with clinical features and outcome. EVI1high was present in 58/206 (28%) patients. MLL rearrangements occurred in 40% of EVI1high patients as opposed to 12% of the EVI1low/absent patients (P < 0·001). No abnormalities of 3q26 were found in EVI1high patients by conventional cytogenetic analysis, nor were cryptic 3q26 abnormalities detected in a subset of patients screened by next‐generation sequencing. French‐American‐British class M7 was enriched in the EVI1high group, accounting for 24% of these patients. EVI1high patients had significantly lower 5‐year overall survival from study entry (51% vs. 68%, P = 0·015). However, in multivariate analysis including other established prognostic markers, EVI1 expression did not retain independent prognostic significance. EVI1 expression is currently being studied in a larger cohort of patients enrolled on subsequent Children's Oncology Group trials, to determine if EVI1high has prognostic value in MLL‐rearranged or intermediate‐risk subsets.Keywords
This publication has 29 references indexed in Scilit:
- deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq DataPLOS Computational Biology, 2011
- Leukemic mutations in the methylation‐associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2011
- CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expressionLeukemia, 2011
- WT1 Synonymous Single Nucleotide Polymorphism rs16754 Correlates With Higher mRNA Expression and Predicts Significantly Improved Outcome in Favorable-Risk Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2011
- Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12Journal of Clinical Oncology, 2010
- High EVI1 Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic AbnormalitiesJournal of Clinical Oncology, 2010
- EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemiaLeukemia, 2010
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective studyBlood, 2009
- EVI1 recruits the histone methyltransferase SUV39H1 for transcription repressionJournal of Cellular Biochemistry, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008